Press Releases
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim    5/16/2024
HKTDC kicks off third International Healthcare Week    5/16/2024
New Research Increases Confidence in the Benefits of Vegan Diets for Dogs    5/16/2024
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status    5/15/2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centre    5/14/2024
Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures    5/13/2024
Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore    5/9/2024
Vinmec's Innovations Spotlighted at Global CSR & ESG Summit 2024    5/9/2024
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea    5/8/2024
Lithuanian Biotech Pioneer 'Nando' Embarks on Global Expansion With New Management Team and Innovative Production Line    5/7/2024
HKTDC launches International Healthcare Week    5/7/2024
JBM Healthcare Issues Positive Profit Alert    5/5/2024
Q&M Dental Enhances Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore    5/2/2024
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg    4/30/2024
CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine    4/26/2024
Elevate Your Sleep Game This World Health Day with LAC    4/25/2024
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China    4/24/2024
Dogs Thrive on Vegan Diets, Demonstrates the Most Comprehensive Study So Far    4/24/2024
China Medical System: New Drug Application of Desidustat Tablets Accepted in China    4/23/2024
New Contaminants, Food Testing & More: analytica Convention 2024 Focuses on Vietnam's Laboratory Needs    4/23/2024
EM2AI Revolutionising the Dental Industry: New AI Products Promise Transparent Treatment Plans for Patients    4/23/2024
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25    4/19/2024
DC Healthcare Rides the Wave of Success with New Openings at Publika and Bukit Indah    4/18/2024
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)    4/18/2024
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan    4/17/2024
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy    4/16/2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology    4/16/2024
Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials    4/9/2024
BYND Cannasoft Announces RSU Grant    4/8/2024
The $7 Billion CBD Market in 2023 is Focused on Significant Growth in Personal Care    4/5/2024
World Hepatitis Summit 2024 Convenes in Lisbon    4/4/2024
A $45 Billion Dollars Market is in the Crosshairs of BYND Cannasoft with a New Series of Concept Smart Fem-Tech Devices    4/3/2024
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization    4/3/2024
French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics    4/3/2024
Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Financial Results For The Year Ended December 31, 2023    4/3/2024
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia    4/1/2024
Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA    4/1/2024
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical    3/29/2024
Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture    3/29/2024
Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024    3/29/2024
Sino Biopharm (1177.HK) Announces 2023 Annual Results    3/29/2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study    3/28/2024
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs    3/28/2024
The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough    3/27/2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System    3/27/2024
BYND Cannasoft Provides Business Update    3/26/2024
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine    3/26/2024
Early Warning News Release for Yftah Ben Yaacov and Carmel Zigdon    3/26/2024
DC Healthcare Continues Growth Momentum with Second DC Body Outlet Opening in USJ Taipan    3/25/2024
Lifenet and Eisai Co-Develop Dementia Insurance "be"    3/21/2024
 
Next >>
 
 
powered by JCN Newswire
 
Other News Sources